| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A case of fatal cetuximab-induced interstitial lung disease during the first weeks of treatment
|
Shablak, Alaaeldin
|
|
2013
|
9 |
2 |
p. 177-180
|
artikel
|
| 2 |
A novel system enhancing the endosomal escapes of peptides promotes Bak BH3 peptide inducing apoptosis in lung cancer A549 cells
|
Lin, Nanjing
|
|
2013
|
9 |
2 |
p. 163-170
|
artikel
|
| 3 |
Anti-leukemic response of a NSAID, tolfenamic acid
|
Sutphin, Robert M.
|
|
2013
|
9 |
2 |
p. 135-144
|
artikel
|
| 4 |
Concurrent sunitinib and stereotactic body radiotherapy for patients with oligometastases
|
Kao, Johnny
|
|
2013
|
9 |
2 |
p. 145-153
|
artikel
|
| 5 |
Erratum to: Recommendations for the clinical and radiological evaluation of response to treatment in metastatic renal cell cancer
|
León, Luís
|
|
2014
|
9 |
2 |
p. 181
|
artikel
|
| 6 |
Interplay between autophagy and apoptosis in pancreatic tumors in response to gemcitabine
|
Papademetrio, Daniela Laura
|
|
2013
|
9 |
2 |
p. 123-134
|
artikel
|
| 7 |
Is availability of anti-EGFR therapy for the colorectal adenocarcinomas showing fascin expression limited?
|
Koçer, Nazım Emrah
|
|
2013
|
9 |
2 |
p. 171-175
|
artikel
|
| 8 |
Lack of KRAS, NRAS, BRAF and TP53 mutations improves outcome of elderly metastatic colorectal cancer patients treated with cetuximab, oxaliplatin and UFT
|
Di Bartolomeo, M.
|
|
2013
|
9 |
2 |
p. 155-162
|
artikel
|
| 9 |
Market access of cancer drugs in European countries: improving resource allocation
|
Pauwels, Kim
|
|
2013
|
9 |
2 |
p. 95-110
|
artikel
|
| 10 |
The success story of trastuzumab emtansine, a targeted therapy in HER2-positive breast cancer
|
Diéras, Véronique
|
|
2013
|
9 |
2 |
p. 111-122
|
artikel
|
Tijdschrift beschrijving